Evidence map›Paper›PMID 40790107›Full record

ArticleNature microbiology2025

Metabolic reprogramming enhances the susceptibility of multidrug- and carbapenem-resistant bacteria to antibiotics.

Su-Fang Kuang, Jiao Xiang, Shao-Hua Li, Yu-Bin Su, Zhuang-Gui Chen, Hui Li, Bo Peng, Xuan-Xian Peng

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Su-Fang KuangState Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Guangdong Province Key Laboratory for Pharmaceutical Functional Genes, Sun Yat-sen University, Guangzhou, China.
Jiao XiangState Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Guangdong Province Key Laboratory for Pharmaceutical Functional Genes, Sun Yat-sen University, Guangzhou, China.
Shao-Hua LiState Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Guangdong Province Key Laboratory for Pharmaceutical Functional Genes, Sun Yat-sen University, Guangzhou, China.
Yu-Bin SuKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Department of Biotechnology, College of Life Science and Technology, Jinan University, Guangzhou, China.ORCID http://orcid.org/0000-0001-5300-7765
Zhuang-Gui ChenDepartment of Pediatrics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. chenzhuanggui@126.com.
Hui LiState Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Guangdong Province Key Laboratory for Pharmaceutical Functional Genes, Sun Yat-sen University, Guangzhou, China. lihui32@sysu.edu.cn.ORCID http://orcid.org/0000-0003-2600-4838
Bo PengState Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Guangdong Province Key Laboratory for Pharmaceutical Functional Genes, Sun Yat-sen University, Guangzhou, China. pengb26@sysu.edu.cn.ORCID http://orcid.org/0000-0002-5698-6097
Xuan-Xian PengState Key Laboratory of Bio-Control, School of Life Sciences, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Guangdong Province Key Laboratory for Pharmaceutical Functional Genes, Sun Yat-sen University, Guangzhou, China. pxuanx@sysu.edu.cn.ORCID http://orcid.org/0000-0002-0200-1395

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32270199National Natural Science Foundation of China (National Science Foundation of China) 42276125
6 · The paper itself

Abstract

Carbapenem-resistant Enterobacteriaceae and extended-spectrum β-lactamase-resistant bacterial pathogens are a major threat to human and global health. Alternative antibiotics are therefore used to treat infections caused by these pathogens, and approaches to increase their efficacy are needed. Here we used metabolomics, mutant Escherichia coli strains and whole-genome sequencing to examine the metabolic profiles of clinical carbapenem-resistant (CR-ECO), multidrug-resistant (MDR-ECO) and antibiotic-sensitive E. coli (S-ECO) isolates in response to antibiotics in vitro including micronomicin, an aminoglycoside. Downregulation of pyruvate formate-lyase (PFL) alters membrane permeability and reduces the efficacy of micronomicin, the most potent antibiotic, in CR-ECO and MDR-ECO. The metabolism of pyruvate to formate is required to potentiate the effects of micronomicin across multiple bacterial pathogens. Mice infected with CR-ECO and treated with formate plus micronomicin had reduced pathogen growth and spread, and increased survival, compared with mice treated with micronomicin or formate alone. Finally, elevated activity or expression of PFL and increased intracellular CO

Indexed as

Anti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeCarbapenemsDrug Resistance, Multiple, BacterialEscherichia coliAnimalsEscherichia coli InfectionsEscherichia coli ProteinsFemaleFormatesHumansMetabolic ReprogrammingMetabolomicsMiceMicrobial Sensitivity TestsPyruvic AcidAnti-Bacterial AgentsCarbapenemsEscherichia coli ProteinsFormatesformic acidPyruvic Acid

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.